# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-000456
Filing Date
2021-01-07
Accepted
2021-01-07 16:15:57
Documents
67
Period of Report
2020-10-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm | 10-K | 1240185
2 |  | ex4-2.htm | EX-4.2 | 70568
3 |  | ex10-10.htm | EX-10.10 | 46043
4 |  | ex10-13.htm | EX-10.13 | 17484
5 |  | ex10-14.htm | EX-10.14 | 355794
6 |  | ex14.htm | EX-14 | 42046
7 |  | ex21.htm | EX-21 | 10689
8 |  | ex23-1.htm | EX-23.1 | 4712
9 |  | ex31-1.htm | EX-31.1 | 16475
10 |  | ex31-2.htm | EX-31.2 | 15317
11 |  | ex32-1.htm | EX-32.1 | 5588
12 |  | ex32-2.htm | EX-32.2 | 6148
13 |  | ex10-10_003.jpg | GRAPHIC | 943
| Complete submission text file | 0001493152-21-000456.txt |  | 5039158

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL INSTANCE FILE | anix-20201031.xml | EX-101.INS | 729388
15 | XBRL SCHEMA FILE | anix-20201031.xsd | EX-101.SCH | 38025
16 | XBRL CALCULATION FILE | anix-20201031_cal.xml | EX-101.CAL | 51437
17 | XBRL DEFINITION FILE | anix-20201031_def.xml | EX-101.DEF | 169185
18 | XBRL LABEL FILE | anix-20201031_lab.xml | EX-101.LAB | 322376
19 | XBRL PRESENTATION FILE | anix-20201031_pre.xml | EX-101.PRE | 250640

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 21514371
SIC: 2834 Pharmaceutical Preparations